Sign in

You're signed outSign in or to get full access.

Autonomix Medical (AMIX)

--

Earnings summaries and quarterly performance for Autonomix Medical.

Research analysts covering Autonomix Medical.

Recent press releases and 8-K filings for AMIX.

Autonomix Medical, Inc. Completes $5.0 Million Private Placement
AMIX
  • Autonomix Medical, Inc. (AMIX) completed a private placement on November 19, 2025, generating approximately $5.0 million in gross proceeds.
  • The offering involved the sale of 4,501,666 pre-funded warrants and 9,003,332 Series C Common Warrants to an institutional investor, with a combined purchase price of $1.1097 per unit.
  • The Common Warrants are exercisable at $0.8607 per share and expire five and one-half years from the initial exercise date.
  • The company intends to use the net proceeds from the offering to fund working capital and general corporate purposes.
  • AMIX will pay Maxim Group LLC a placement agent fee of up to 8% of the gross proceeds and reimburse up to $50,000 for fees and expenses.
Nov 19, 2025, 9:15 PM
Autonomix Medical, Inc. Enters into $15 Million Common Stock Purchase Agreement
AMIX
  • Autonomix Medical, Inc. (AMIX) entered into a Purchase Agreement with Lincoln Park Capital Fund, LLC on August 25, 2025, allowing AMIX to sell up to $15.0 million in shares of its common stock to Lincoln Park over a period of up to 24 months.
  • The purchase price for each Regular Purchase will be 97.0% of the lower of (i) the lowest sale price on the business day the Company initiates the purchase or (ii) the average of the three lowest closing sale prices during the 10-business day period immediately preceding the purchase day.
  • As consideration for Lincoln Park's commitment to purchase shares, AMIX issued 261,932 shares of common stock (Commitment Shares) to Lincoln Park on August 25, 2025.
  • Sales are at the Company's sole discretion and are subject to certain limitations, including a Nasdaq Exchange Cap of 19.99% of outstanding shares (unless stockholder approval is obtained or the average price equals or exceeds $1.3351 per share) and a beneficial ownership limit for Lincoln Park of 4.99% of outstanding common stock.
  • Any proceeds received from these sales are expected to be used for working capital and general corporate purposes.
Aug 26, 2025, 12:00 AM